Lyra Therapeutics, Inc.

Q2 2023 13F Holders

Symbol: LYRA
CUSIP: 55234L105
Type: Equity
Class: COM
Num filings: 43
Total reported value, excl. options: $138 M

Compare 2023 Q2 to

Manager	Report Date	Value ($000)	Shares	Option Type